Description de l’essai
Phase I/II study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of SAR439859, administered orally as monotherapy, then in combination with palbociclib in postmenopausal women with estrogen receptor positive advanced breast cancer
Trial sponsor
SANOFI AVENTIS
Médecin ICO - Saint-Herblain
MARIO CAMPONE
Type d'intervention évaluée
Thérapeutique
Date de début de l'essai
28/08/2017
Lien de l'étude : clinicaltrials.gov
